Pomalidomide Plus Rituximab Maintenance in Young High-Risk Newly Diagnosed DLBCL After First-Line Response
Clinical trial NCT07760610 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07760610
- Sponsor
- The First Hospital of Jilin University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2028-07-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.